14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ADMS
Delisted

Adamas Pharmaceuticals Stock Price (Quote)

$8.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $8.22 $8.22 Friday, 27th May 2022 ADMS stock ended at $8.22. During the day the stock fluctuated 0% from a day low at $8.22 to a day high of $8.22.
90 days $8.22 $8.22
52 weeks $4.02 $8.25

Historical Adamas Pharmaceuticals prices

Date Open High Low Close Volume
Mar 27, 2019 $7.48 $7.50 $7.12 $7.20 348 318
Mar 26, 2019 $7.33 $7.51 $7.33 $7.48 246 132
Mar 25, 2019 $7.65 $7.65 $7.26 $7.30 385 846
Mar 22, 2019 $7.95 $7.99 $7.66 $7.66 293 236
Mar 21, 2019 $7.92 $8.09 $7.89 $7.99 269 938
Mar 20, 2019 $7.99 $8.25 $7.90 $8.01 397 633
Mar 19, 2019 $7.85 $8.04 $7.81 $7.99 314 105
Mar 18, 2019 $7.83 $7.95 $7.70 $7.83 286 314
Mar 15, 2019 $7.89 $8.24 $7.79 $7.81 749 495
Mar 14, 2019 $7.51 $7.95 $7.43 $7.90 482 525
Mar 13, 2019 $7.79 $7.82 $7.48 $7.50 633 103
Mar 12, 2019 $7.56 $7.80 $7.52 $7.71 427 700
Mar 11, 2019 $7.76 $7.82 $7.46 $7.55 589 198
Mar 08, 2019 $7.85 $7.99 $7.64 $7.76 577 461
Mar 07, 2019 $7.81 $8.00 $7.57 $7.87 1 600 106
Mar 06, 2019 $8.33 $8.55 $7.60 $7.77 3 163 024
Mar 05, 2019 $8.70 $9.05 $8.11 $8.16 5 213 791
Mar 04, 2019 $12.00 $12.57 $11.66 $12.15 892 532
Mar 01, 2019 $11.40 $11.80 $11.07 $11.80 508 322
Feb 28, 2019 $11.00 $11.23 $10.87 $11.19 187 478
Feb 27, 2019 $11.00 $11.26 $10.88 $10.97 191 482
Feb 26, 2019 $11.48 $11.48 $10.98 $11.08 224 222
Feb 25, 2019 $11.32 $11.47 $11.12 $11.26 309 424
Feb 22, 2019 $11.00 $11.14 $10.88 $11.11 190 227
Feb 21, 2019 $11.27 $11.78 $10.81 $10.99 484 351
Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT